Quantcast

Latest Management of prostate cancer Stories

2014-12-22 08:27:30

First study to show that the genomic signature of prostate cancer can predict rapid development of metastatic disease in men who were managed conservatively after surgery SAN DIEGO, Dec.

2014-11-12 20:22:48

Statement from the primary funder, the Movember Foundation, in response to the research paper - Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence

2014-11-04 12:28:22

PATIENT SELECTION PREDICTS EXCELLENT PROSTATE CANCER TREATMENT SARASOTA, Fla., Nov.

2014-10-30 16:29:47

Opportunities Being Developed While the Situation with the PCA3 Prostate Cancer Test is Being Resolved QUEBEC CITY, Oct. 30, 2014 /PRNewswire/ - DiagnoCure, Inc.

2014-10-24 23:01:37

SonaCare Medical, LLC, leader in minimally invasive high intensity focused ultrasound (HIFU) technology, announced that its Board of Directors has appointed Dr. Mark Carol, M.D.

2014-10-03 23:00:25

SonaCare Medical FDA Panel Review for Its Sonablate® 450 Prostate Ablation System CHARLOTTE, NC (PRWEB) October 03, 2014 FRIDAY, OCTOBER 3, 2014

2014-09-29 08:29:46

Final data after 49-month follow-up analysis in chemotherapy-naïve men with metastatic castration-resistant prostate cancer presented at European Society for Medical Oncology (ESMO) 2014 Congress

2014-09-28 08:21:14

Final analysis of Phase 3 COU-AA-302 study presented at the European Society for Medical Oncology (ESMO) 2014 Congress HORSHAM, Pa., Sept.

2014-09-17 20:22:13

Oral presentation at American Society for Radiation Oncology Annual Meeting describes Decipher's ability to identify high-risk prostate cancer patients that may benefit from radiation therapy after


Word of the Day
edulcoration
  • The act of sweetening by admixture of some saccharine substance.
The word 'edulcoration' comes from a Latin word meaning 'making sweet'.